510(k) K062368
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 31, 2007
- Date Received
- August 14, 2006
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Des-Gamma-Carboxy-Prothrombin (Dcp), Risk Assessment, Hepatocellular Carcinoma
- Device Class
- Class II
- Regulation Number
- 866.6030
- Review Panel
- IM
- Submission Type
The test is intended to quantitatively measure dcp in human serum and use as an aid in the risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma (hcc) in conjunction with other laboratory findings, imaging studies and clinical assessment for risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma.